JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Big investors are zeroing in on age reversal research by biotech firms, with massive funding accelerating the pace of such studies. Among the biotech companies benefitting from the growth in the field is Hong Kong-based Insilico Medicine. CNA’s Dawn Tan reports.
